Journal article · 2026 · Open access

Colorectal cancer screening: An update to the American Cancer Society guideline, 2026

Andrew M. D. Wolf, Richard M. Hoffman, Louise Christie Walter, Charnita M Zeigler-Johnson, Timothy R. Church, Carmen E. Guerra, Elena B. Elkin, Ruth Etzioni, Abbe H. Herzig, Kevin Charles Oeffinger, Rebecca B. Perkins, Sana Raoof and 5 more

CA A Cancer Journal for Clinicians, 76(3), e70083 · Published 1 May 2026 · DOI 10.3322/caac.70083

Open full textCite this paper

In brief

“Colorectal cancer screening: An update to the American Cancer Society guideline, 2026” is a 2026 journal article by Andrew M. D. Wolf and 16 co-authors, published in CA A Cancer Journal for Clinicians. OpenAlex counts 26 citations as of 17 November 2026, which puts it in the top 1% of works published in 2026 by citations. It is open access under a CC BY-NC-ND licence: the full text is free to read at CA A Cancer Journal for Clinicians.

Citations
26
Most cited in
2026 (26)
Field-weighted impact
52.72
References
53
Authors
17

Abstract

Colorectal cancer (CRC) is a leading cause of cancer incidence and mortality in the United States, with rates recently increasing among adults younger than 65 years. In 2018, the American Cancer Society (ACS) lowered the recommended age to initiate screening for average-risk adults to age 45 years. Since then, new molecular-based screening tests-a multitarget stool RNA test (mt-sRNA), a next-generation mt-sDNA test, and a blood-based cell-free DNA assay-have received regulatory approval for CRC screening. For this update, the ACS Guideline Development Group commissioned a targeted, systematic evidence review evaluating diagnostic performance and published modeling studies to judge the potential impact of these tests on CRC incidence and mortality. The ACS reaffirms the recommendation that average-risk adults should initiate CRC screening at age 45 years and continue through age 75 years for those with a life expectancy greater than 10 years. Consistent with prior guidelines, the ACS emphasizes that offering multiple, recommended screening options supports informed patient choice and may improve participation, because the most effective screening test is the one that the patient completes. The next-generation mt-sDNA test, which is an updated version of an already recommended mt-sDNA test, and the mt-sRNA test demonstrated high sensitivity for CRC and moderate sensitivity for advanced precancerous lesions and are recommended, along with annual high-sensitivity fecal immunochemical and high-sensitivity guaiac-based fecal occult blood tests, as preferred stool-based screening options at 3-year intervals. Compared with established stool-based tests, blood-based tests demonstrated lower sensitivity for both advanced precancerous lesions and stage I cancers, with modeling studies predicting less effectiveness in reducing CRC incidence and mortality. At this time, blood-based tests should be recommended only to individuals who decline or do not complete preferred screening tests. Ongoing evaluation of adherence, real-world implementation, and clinical outcomes will inform future updates for these new tests. For screening to be effective, a positive result on any noncolonoscopy screening test requires timely follow-up with colonoscopy, preferably within 6 months, to complete the screening process.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Wolf, A. M. D., Hoffman, R. M., Walter, L. C., Zeigler-Johnson, C. M., Church, T. R., Guerra, C. E., Elkin, E. B., Etzioni, R., Herzig, A. H., Oeffinger, K. C., Perkins, R. B., Raoof, S., Shih, Y.-C. T., Skates, S. J., Kratzer, T. B., Manassaram‐Baptiste, D., & Smith, R. A. (2026). Colorectal cancer screening: An update to the American Cancer Society guideline, 2026. CA A Cancer Journal for Clinicians, 76(3), e70083. https://doi.org/10.3322/caac.70083

MLA 9

Wolf, Andrew M. D., et al. “Colorectal cancer screening: An update to the American Cancer Society guideline, 2026.” CA A Cancer Journal for Clinicians, vol. 76, no. 3, 2026, p. e70083. https://doi.org/10.3322/caac.70083.

Chicago

Wolf, Andrew M. D., Richard M. Hoffman, Louise Christie Walter, Charnita M Zeigler-Johnson, Timothy R. Church, Carmen E. Guerra, Elena B. Elkin, et al. 2026. “Colorectal cancer screening: An update to the American Cancer Society guideline, 2026.” CA A Cancer Journal for Clinicians 76 (3): e70083. https://doi.org/10.3322/caac.70083.

Harvard

Wolf, A. M. D. et al. (2026) ‘Colorectal cancer screening: An update to the American Cancer Society guideline, 2026’, CA A Cancer Journal for Clinicians, 76(3), p. e70083. doi:10.3322/caac.70083.

IEEE

A. M. D. Wolf et al., “Colorectal cancer screening: An update to the American Cancer Society guideline, 2026,” CA A Cancer Journal for Clinicians, vol. 76, no. 3, p. e70083, 2026, doi: 10.3322/caac.70083.

BibTeX

@article{wolf2026colorectal,
  title     = {{Colorectal cancer screening: An update to the American Cancer Society guideline, 2026}},
  author    = {Wolf, Andrew M. D. and Hoffman, Richard M. and Walter, Louise Christie and Zeigler-Johnson, Charnita M and Church, Timothy R. and Guerra, Carmen E. and Elkin, Elena B. and Etzioni, Ruth and Herzig, Abbe H. and Oeffinger, Kevin Charles and Perkins, Rebecca B. and Raoof, Sana and Shih, Ya-Chen Tina and Skates, Steven J. and Kratzer, Tyler B. and Manassaram‐Baptiste, Deana and Smith, Robert A.},
  journal   = {CA A Cancer Journal for Clinicians},
  year      = {2026},
  volume    = {76},
  number    = {3},
  pages     = {e70083},
  doi       = {10.3322/caac.70083},
  url       = {https://doi.org/10.3322/caac.70083}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Medicine › Oncology › Colorectal Cancer Screening and Detection

  • colorectal cancer screening
  • American Cancer Society guidelines
  • multi-target stool DNA test
  • fecal immunochemical test
  • guaiac-based fecal occult blood test
  • advanced precancerous lesions
  • colorectal cancer incidence and mortality
  • follow-up colonoscopy

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Wolf, A. M. D., Hoffman, R. M., Walter, L. C., Zeigler-Johnson, C. M., Church, T. R., Guerra, C. E., Elkin, E. B., Etzioni, R., Herzig, A. H., Oeffinger, K. C., Perkins, R. B., Raoof, S., Shih, Y.-C. T., Skates, S. J., Kratzer, T. B., Manassaram‐Baptiste, D., & Smith, R. A. (2026). Colorectal cancer screening: An update to the American Cancer Society guideline, 2026. CA A Cancer Journal for Clinicians, 76(3), e70083. https://doi.org/10.3322/caac.70083

How many times has this paper been cited?

26 times, according to OpenAlex on 17 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at CA A Cancer Journal for Clinicians: sign in and open the full text from this page.

Who wrote this paper?

Andrew M. D. Wolf, Richard M. Hoffman, Louise Christie Walter, Charnita M Zeigler-Johnson, Timothy R. Church, Carmen E. Guerra, Elena B. Elkin, Ruth Etzioni, Abbe H. Herzig, Kevin Charles Oeffinger, Rebecca B. Perkins, Sana Raoof and 5 more.

What is the DOI of this paper?

10.3322/caac.70083, permanently at https://doi.org/10.3322/caac.70083. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 17 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.